Finding that links ALS/ataxia to cellular stress opens new approaches for treatment
Friday, September 7, 2018 - 16:31
in Health & Medicine
Scientists report for the first time that a protein, called Staufen1, accumulates in cells of patients suffering from degenerative ataxia or amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig's disease. Depleting the protein from affected mice improved symptoms including motor function.